Navigation Links
Schering-Plough Highlights Hepatitis C Clinical Data Presentations at the European Association for the Study of the Liver (EASL) Annual Meeting
Date:4/26/2009

ith REBETOL is preferred over PEGINTRON monotherapy unless there are contraindications to, or significant intolerance of, REBETOL. Combination therapy provides substantially better response rates than monotherapy.

Important Safety Information Regarding U.S. Labeling for PEGINTRON and REBETOL

WARNING: RISK OF SERIOUS DISORDERS AND RIBAVIRIN-ASSOCIATED EFFECTS

Alpha interferons, including PEGINTRON, may cause or aggravate fatal or life-threatening neuropsychiatric, autoimmune, ischemic, and infectious disorders. Patients should be monitored closely with periodic clinical and laboratory evaluations. Patients with persistently severe or worsening signs or symptoms of these conditions should be withdrawn from therapy. In many, but not all cases, these disorders resolve after stopping PEGINTRON therapy.

Use with Ribavirin: Ribavirin may cause birth defects and death of the unborn child. Extreme care must be taken to avoid pregnancy in female patients and in female partners of male patients. Ribavirin causes hemolytic anemia. The anemia associated with REBETOL therapy may result in a worsening of cardiac disease. Ribavirin is genotoxic and mutagenic and should be considered a potential carcinogen.

Contraindications

PEGINTRON is contraindicated in patients with known hypersensitivity reactions such as urticaria, angioedema, bronchoconstriction, anaphylaxis, Stevens Johnson syndrome and toxic epidermal necrolysis to interferon alpha or any other component of the product, autoimmune hepatitis, and hepatic decompensation (Child-Pugh score greater than 6 [class B and C]) in cirrhotic CHC patients before or during treatment. PEGINTRON/REBETOL combination therapy is additionally contraindicated in women who are pregnant or may become pregnant (see Boxed Warning and Pregnancy section), men whose female partners are pregnant, patients with hemoglobinopathies (e.g., tha
'/>"/>

SOURCE Schering-Plough Corporation
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11

Related medicine technology :

1. Schering-Plough Initiates Phase III Studies with Vicriviroc in Treatment- Experienced HIV Patients
2. Pharmacopeia Earns Milestone Payment From Schering-Plough on Initiation of Phase 1 Clinical Trials of Novel Therapeutic Candidate
3. Schering-Plough Highlights PEGINTRON(TM) Clinical Data Presentations at the American Association for the Study of Liver Diseases (AASLD) 2007 Annual Meeting
4. Schering-Plough Announces Asenapine NDA Accepted for Filing by the U.S. FDA
5. Schering-Plough Reports Top-Line Results of the IDEAL Study
6. Parker Waichman Alonso LLP and Affiliated Lawfirms Have Filed a Class Action Lawsuit in the United States District Court for the Eastern District of New York Against Merck & Co., Inc. and Schering-Plough Corporation
7. Schering-Plough Initiates Phase II Study With Vicriviroc in Treatment-Naive HIV-Infected Patients
8. Schering-Plough Announces Imperfect Contraceptive Use Impacts Womens Emotional Well-Being
9. Schering-Plough Highlights PEGINTRON(TM) and Boceprevir Data Presentations at European Association for the Study of the Liver (EASL) Annual Meeting
10. Schering-Plough Highlights PEGINTRON(TM) and Boceprevir Hepatitis C Data Presentations at Digestive Disease Week (DDW) Annual Meeting
11. Schering-Plough To Initiate Phase III Studies With HCV Protease Inhibitor Boceprevir in Previously Untreated Hepatitis C Patients and Those Who Failed Prior Treatment
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/5/2015)...  Medical Diagnostic Laboratories, L.L.C., (MDL), a CLIA-certified, ... automated DNA-based molecular analyses, announces that it is ... utilizes cutting edge technology, including next- generation DNA ... women are diagnosed with cervical cancer in ... Papillomaviruses (HPV) are a group of more than ...
(Date:3/5/2015)... Minn. , March 5, 2015  ANI ... today announced that it has acquired the approved ... tablets USP 50mg, 100mg and 150mg, previously marketed ... overall market for this product was approximately $39 ... S. Przybyl , President and CEO of ANI ...
(Date:3/5/2015)... DUBLIN , Mar. 05, 2015 Research and ... addition of the "Japan Pharma Outlook 2015: Year ... Overseas Strategic Initiatives" report to their offering. ... Japan from April -2014 (Annexure 1) ... the companies - whether generic or innovator. The most ...
Breaking Medicine Technology:Medical Diagnostic Laboratories, L.L.C., the Institute for Biomarker Research Announces New HPV Tests 2Medical Diagnostic Laboratories, L.L.C., the Institute for Biomarker Research Announces New HPV Tests 3ANI Pharmaceuticals Acquires Generic Drug Product from Teva Pharmaceuticals 2ANI Pharmaceuticals Acquires Generic Drug Product from Teva Pharmaceuticals 3Japan Pharma Outlook 2015: Year to Watch out for Authorized Generics (AGs), Biosimilars and Overseas Strategic Initiatives 2Japan Pharma Outlook 2015: Year to Watch out for Authorized Generics (AGs), Biosimilars and Overseas Strategic Initiatives 3
... PORTSMOUTH, Va., Oct. 27 ViVre Medical today launches ... consumers to arm themselves with information that may potentially save ... is a system that is designed to help ensure critical ... in situations where patients are unable to speak for themselves. ...
... Endologix, Inc. (Nasdaq: ELGX ), developer of ... results for the three and nine months ended September ... Chief Executive Officer, said, "Our strong third quarter financial ... by our domestic sales force and better than expected ...
Cached Medicine Technology:ViVre Medical Launches Lifesaving Medical Device 2Endologix Reports 47% Third Quarter 2009 Revenue Growth 2Endologix Reports 47% Third Quarter 2009 Revenue Growth 3Endologix Reports 47% Third Quarter 2009 Revenue Growth 4Endologix Reports 47% Third Quarter 2009 Revenue Growth 5Endologix Reports 47% Third Quarter 2009 Revenue Growth 6Endologix Reports 47% Third Quarter 2009 Revenue Growth 7Endologix Reports 47% Third Quarter 2009 Revenue Growth 8
(Date:3/5/2015)... For PASCHA Chocolate, less is more. ... robust flavor of the cacao bean bursts through without ... free from peanuts, nuts, dairy, soy, eggs, fish, wheat, ... 8th at Expo West., ,    NEW PASCHA Make ... new ground with their New PASCHA Make Me Smile! ...
(Date:3/5/2015)... Harrisburg, NC (PRWEB) March 05, 2015 ... of Physician Assistants’ (AAPA) review of Clearstream, ... AAPA determined that Clearstream’s MediDefense line of products—led ... of the AAPA’s Affinity Partner Program. , The ... physician assistants across all medical and surgical specialties ...
(Date:3/5/2015)... 05, 2015 Nutrition Leaders, a premier ... pleased to offer reformulated Millennium 500 Creatine to its ... is a German grade creatine supplement that has been ... recovery, and aid with overall strength gains in users. ... as a reserve energy source in the body and ...
(Date:3/5/2015)... 05, 2015 Think it’s tough to get ... to get them to brush their teeth. That’s a finding ... today by Delta Dental(1) in conjunction with National Parenting Month ... say getting kids to brush their teeth is one of ... That’s slightly higher than getting children to eat vegetables regularly ...
(Date:3/5/2015)... The law firm of Momkus McCluskey, LLC ... Crain’s Chicago Business Physicians' Breakfast on Wednesday, March 11, ... place from 7:30 to 9:45 a.m. at the Ritz-Carlton ... The morning’s events will include a moderated panel discussion ... The panel discussion is focused on physicians navigating a ...
Breaking Medicine News(10 mins):Health News:PASCHA Allergen Free Organic Chocolate to Appear at Natural Products Expo West March 6-8, 2015 2Health News:Clearstream’s Line of MediDefense Antimicrobial Products Scores Affinity Partnership With American Academy of Physician Assistants (AAPA) 2Health News:Clearstream’s Line of MediDefense Antimicrobial Products Scores Affinity Partnership With American Academy of Physician Assistants (AAPA) 3Health News:Clearstream’s Line of MediDefense Antimicrobial Products Scores Affinity Partnership With American Academy of Physician Assistants (AAPA) 4Health News:Nutrition Leaders Offers Reformulated Millennium 500 German Grade Creatine 2Health News:Delta Dental Survey Says Parents Have Harder Time Getting Kids to Brush than to Eat Vegetables 2Health News:Delta Dental Survey Says Parents Have Harder Time Getting Kids to Brush than to Eat Vegetables 3Health News:Cook County Law Firm to Sponsor Physicians Breakfast 2
... Allison Kurian, MD, and her colleagues at the Stanford ... to identify women who might have dangerous genetic mutations ... worked well for white women. But they seemed to ... been repeatedly surprised when Asian women who the models ...
... and celebrate fifteen,years of Education, Advocacy, and Research!, ... Cancer Coalition (PBCC) Annual Conference will be held ... & Towers from 7 a.m. to 3:30 p.m.,in ... and research., Pat Halpin-Murphy, President and Founder ...
... Southern Home Medical,Equipment, Inc. (OTC: SHOM) announced today that ... compared to July 2008., Greg Tucker, President and ... record sales in the second quarter of this year, ... sales momentum. Encore Medical Staffing is,dedicated to improving the ...
... family also has serious consequences for the children,s growth, ... University has studied women and their children in Bangladesh ... whose mothers are exposed to violence grow less and ... Kajsa sling Monemi, paediatrician, the Department of Women,s and ...
... Non-US Healthcare Media, - Global QUEST Study Reveals ... With Vetmedin(R) (pimobendan), Veterinarians and dog owners are ... extended happy life together for millions of dog,owners and ... the most common type of heart failure live on ...
... Right, Move More ... and Milk Their Diets, BOSTON, Sept. 11 The last ... which seem to go in and out of,fashion like shoulder pads and hemlines. ... percent of Massachusetts,residents -- remain overweight or obese., A new campaign crossing ...
Cached Medicine News:Health News:Risk of breast cancer mutations underestimated for Asian women, Stanford study shows 2Health News:Risk of breast cancer mutations underestimated for Asian women, Stanford study shows 3Health News:Pennsylvania Breast Cancer Coalition Hosts Annual Conference 2Health News:Southern Home Medical Announces Revenues Up 172% for the Month of August 2Health News:Landmark Research Heralds New Era in Dog Heart Treatment and Longer Life for Dogs 2Health News:Landmark Research Heralds New Era in Dog Heart Treatment and Longer Life for Dogs 3Health News:Landmark Research Heralds New Era in Dog Heart Treatment and Longer Life for Dogs 4Health News:Message to Boston Residents: Forgo Fad Dieting and Join the Campaign for Healthy Weight 2Health News:Message to Boston Residents: Forgo Fad Dieting and Join the Campaign for Healthy Weight 3Health News:Message to Boston Residents: Forgo Fad Dieting and Join the Campaign for Healthy Weight 4
... catheters provide a simple, efficient and ... in the heart or cardiovascular system. ... ideal for high fidelity pressure measurement. ... 2 to 7 French and in ...
... Mikro-Tip pressure intravascular catheters provide a ... of measuring pressures in the heart ... Mikro-Tip catheters are ideal for high ... in size from 2 to 7 ...
... These dual pressure sensor catheters ... injection, slow-speed injection/guide wire, or ... SPC-784A for high-speed injection has ... openings and an open-end pigtail ...
... Intravascular Mikro-Tip Pressure Catheters; Millar manufactures ... pressure sensor catheters for simultaneous high ... suitable for measuring pressure gradients across ... a vascular stenosis. The catheters are ...
Medicine Products: